Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was later reported that the patient's generator is prematurely depleting.It was normal last week at around 80% and it was around 25% a week later.The patient continues to receive dialysis at least once a week.The representative also reported that there actually was no cardioversion or exposure to electrocautery event last fall, and they are unclear what caused his battery depletion.There was no surgery that occurred during this time either.Updated internal generator data was received and reviewed.Based on the data, the generator appears to be prematurely depleting.No known relevant surgical intervention has occurred to date.No other relevant information has been received to date.
|